Achillion Pharmaceuticals

INVESTORS

SEC Filings

 
SEC Filings
Date Filing Description View
Apr 20, 2018 DEF 14A definitive proxy statement HTML PDF XLS
565.8 KB
Feb 22, 2018 8-K current report HTML PDF XLS
222.4 KB
Feb 22, 2018 10-K annual report HTML PDF XLS XBRL
861.6 KB
Feb 14, 2018 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
137.0 KB
Feb 14, 2018 SC 13G/A amended statement of beneficial ownership HTML PDF XLS
135.0 KB
Feb 13, 2018 4 deshpande, milind HTML PDF XLS
152.0 KB
Feb 13, 2018 4 fenton, mary kay HTML PDF XLS
152.3 KB
Feb 13, 2018 4 manning, martha e HTML PDF XLS
152.0 KB
Feb 13, 2018 4 truitt, joseph HTML PDF XLS
152.6 KB
Feb 13, 2018 4 fisherman, jason s HTML PDF XLS
152.5 KB
1
...
NextLast